Genetic risk for severe lung affection during COVID-19 

The purpose of the study is to identify genetic factors that may educate the biological understanding of the development of severe lung disease in COVID-19 infection. Such an understanding may inform treatment trials of potential utility towards more effective management of this patient group. A polygenic risk score may also be useful in identifying high/low risk patients, e.g. amongst health-care providers and vulnerable individuals with significant comorbidities.

Project leader:

Tom Hemming Karlsen

Page visits: 6658